Banagan, Baby Girl .
HRN: 28-64-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/04/2026
03/10/2026
IV
50mg
Q8H
Dengue Shock Syndrome; ATP
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines